In this article, we discuss the 5 stocks boasting double-digit gains. For a deeper discussion and an extended list, please see 10 High-Flying Stocks With Double-Digit Returns.

5. Intel Corp. (NASDAQ:INTC)

Intel climbed to a new all-time high on Friday, as investors gobbled up shares after reporting robust revenues in the first quarter of the year.

At the intra-day session, the stock surged to its highest price of $85.22 before trimming gains to finish the day just up by 23.60 percent at $82.54 apiece.

In an updated report, Intel Corp. (NASDAQ:INTC) said that it was able to grow its revenues by 7 percent to $13.6 billion from $12.7 billion in the same period last year, on the back of growing demand for CPUs in the artificial intelligence era, coupled with unprecedented demand for silicon products. However, it remained at an attributable net loss of $3.7 billion versus $800 million in the same period last year.

Further buoying sentiment was the company’s upbeat outlook for its business, with CEO Lip-Bu Tan saying that the next wave of AI will significantly increase the need for Intel Corp.’s (NASDAQ:INTC) CPUs, wafers, and advanced packaging offerings.

“We are addressing this opportunity by listening to our customers and driving their success with our technical expertise and differentiated IP. This deliberate reset to how we operate drove a sixth consecutive quarter of revenue above our expectations, as well as new and deepened relationships with strategic partners,” he said.

For the second quarter of the year, Intel Corp. (NASDAQ:INTC) is targeting to grow its revenues by 7 percent to 15 percent to a range of $13.8 billion to $14.8 billion, versus the $12.9 billion posted in the same period last year.

It also expects to swing to a diluted earnings per share attributable to the company of $0.08, versus a $0.67 diluted loss per share attributable to the firm registered year-on-year.

4. POET Technologies Inc. (NASDAQ:POET)

POET Technologies saw its share prices climb to an over 11-year high, as investors piled into the photonics sector following earlier confirmation that it secured orders from Marvell Technologies, while awaiting responses from two more large customers.

In intra-day trading, the stock climbed to a record high of $15.50 before trimming gains to end the session just up by 28.84 percent at $15.10 apiece. The last time POET Technologies Inc. (NASDAQ:POET) touched the said level was in August 2014.

A report by Stocktwits said earlier in the week that POET Technologies Inc. (NASDAQ:POET) chief finance officer Thomas Mika confirmed that the company officially secured orders from Marvell Technologies, which is expected to boost its total orders to more than $5 million for this year.

Deliveries, the report said, are targeted to begin in the third quarter of the year.

Additionally, the company is awaiting the confirmation of two more potential clients, namely Foxconn and Luxshare.

“We expect to hear back from at least one of those,” Mika was quoted as saying.

Despite the news, former hedge fund manager and Mad Money host Jim Cramer deemed it too early to load portfolios on POET Technologies Inc. (NASDAQ:POET).

“Let’s not get ahead of ourselves with these recent announcements. POET’s got a joint development agreement. They’re not producing this stuff at scale. I’m calling it early. The stock’s trading like they’re already in mass production, and that bothers me. Just look at the numbers. POET’s financials make it look more of a science project than a business,” Cramer said.

“With a company like this, the challenge is never just whether the technology works in a lab demo. You gotta figure out if it can be manufactured consistently and shipped at what we call scale.”

3. Organon & Co. (NYSE:OGN)

Organon bounced back by 30.93 percent on Friday to close at $11.26 apiece, as investors snapped up shares following news that Sun Pharmaceuticals is upsizing its takeover offer of the company to $13 billion.

A report by The Economic Times said on the same day that Sun Pharma submitted a binding offer to acquire Organon & Co. (NYSE:OGN) for $13 billion, versus the $12 billion it offered initially.

It said that Sun Pharma has already secured the backing of three global lenders, including JPMorgan, MUFG, and Citi.

Organon & Co. (NYSE:OGN) was spun off from Merck in 2021. It is engaged in the development of therapies for reproductive health, women’s health, and contraception, among others.

Earlier this year, the listed US-based firm announced results from the late-stage clinical trial of its VTAMA cream—the only aryl hydrocarbon receptor (AhR) agonist indicated for the treatment of both plaque psoriasis in adults, as well as atopic dermatitis (AD) in adults and pediatric patients aged 2 years and above.

Based on the results, the treatment candidate demonstrated early and consistent improvement in disease severity, as measured by vIGA-AD and EASI, and itch, as measured by PP-NRS, for patients down to age 2 with moderate to severe AD.

2. X-Energy Inc. (NASDAQ:XE)

Amazon-backed X-Energy soared by as much as 36 percent in its first day as a publicly listed company, as investors gobbled up its shares amid the strong optimism and rosy prospects for the nuclear sector.

X-Energy Inc. (NASDAQ:XE) opened the day immediately, clocking a 30.9-percent gain at $30.11, then soared to its highest price of $31.33, before finishing the session at $29.20. It priced its initial public offering (IPO) at $23 apiece.

The company—now valued at $11.5 billion—successfully raised $1.017 billion from its IPO, covering more than 44.2 million Class A shares.

In connection with the offering, X-Energy Inc. (NASDAQ:XE) also granted its underwriters a 30-day option to purchase up to an additional 6.6 million shares. If fully subscribed, this would increase its offer by another $152.68 million, for a total of $1.169 billion.

X-Energy Inc. (NASDAQ:XE) is a leading developer of advanced small modular nuclear reactors and fuel technology for clean energy generation.

In 2024, it earned the backing of e-commerce giant Amazon by being both an investor and a client, as the latter ramps up its plans to secure energy services from small modular reactors.

1. MaxLinear Inc. (NASDAQ:MXL)

MaxLinear climbed for 13 straight days on Friday, to propel its share price to a fresh four-year high, after posting a strong earnings performance for the first three months of the year and an upbeat outlook for the second quarter.

In intra-day trading, MaxLinear Inc. (NASDAQ:MXL) climbed by as much as 85 percent to a record high of $63.52, before paring gains to end the session just up by 76.12 percent at $60.32 apiece.

This followed a 43-percent growth in revenues in the first quarter of the year, at $137 million versus the $95.9 million in the same period a year earlier. Net loss narrowed by 9.45 percent to $45 million from $49.7 million year-on-year.

MaxLinear Inc. (NASDAQ:MXL) Chairman and CEO Kishore Seendripu pointed to the strong momentum for optical data center connectivity as having bolstered its earnings performance for the period.

“Revenue grew 43 percent year over year, with infrastructure growing more than 130 percent to become our largest end market. This was driven primarily by strong execution and production ramps of our optical data center products at multiple hyperscale customers across scale-up and scale-out AI platforms,” he said.

Following the results, MaxLinear Inc. (NASDAQ:MXL) said that it is now at a clear inflection point in its optical data center business, marked by a step function increase in second-quarter revenues.

For the April to June period, the company is targeting to grow its revenues by 47 percent to 56 percent to a range of $160 million to $170 million, versus $108.8 million in the same period last year.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.